Bausch Health and YUN Expand Their Partnership to Mexico and EMEA Markets

Bausch Health and YUN Strengthen Their Market Presence in EMEA and Mexico

In a significant stride towards expanding their global operations, Bausch Health Companies Inc. (NYSE: BHC) and Belgian innovator YUN have partnered to extend their reach into Mexico and other EMEA (Europe, the Middle East, and Africa) markets. This venture follows Bausch Health's successful entry into the Polish market in 2025, showcasing the companies' commitment to providing scientifically-backed skincare solutions.

The collaboration marks a substantial enhancement in both the product assortment and geographical footprint of Bausch Health's dermatological product portfolio. In Poland, the company strategically integrated YUN's skin care products tailored for eczema-prone skin, building on the previous launch of probiotic products for acne-prone conditions. This expansion reflects Bausch Health's goal of offering innovative skincare solutions to patients and consumers across diverse regions.

New Market Ventures

The venture involves the introduction of YUN products specifically designed for both acne and eczema treatment in various Eastern European markets. The long-awaited entry into the Czech Republic, Slovakia, Ukraine, and Bulgaria signifies a pivotal moment in their expansion strategy. Additionally, the launch in Mexico marks a crucial phase in garnering a wider audience for YUN’s probiotic skincare technology, with further plans to penetrate the Kazakh market by October 2026.

Cees Heiman, Senior Vice President of Bausch Health for Europe and Canada, articulated the brand's ambition, stating, "Following our successful collaboration in Poland, YUN has embarked on its journey into additional markets, aligning perfectly with our broader growth strategy across EMEA. Our expansion to new territories underscores our commitment to delivering unique evidence-based healthcare and skincare solutions worldwide. The EMEA region remains strategically significant for Bausch Health, where we see robust potential for the YUN microbiome-focused brand."

Delivering Value to Consumers

Fernando Zarate, Vice President of Bausch Health for Latin America, expressed enthusiasm about the brand's Mexican debut, saying, "The introduction of YUN expands our dermatological offerings with scientifically-grounded skincare solutions that respond to evolving consumer needs in Mexico. Our goal is to broaden access to innovative dermatological products and we are excited to do this in Mexico."

The CEO and founder of YUN, Tom Verlinden, also remarked on the collaboration, emphasizing the mission to leverage their proprietary YUN Probiotherapy™ technology. This unique platform facilitates the stable application of live probiotics in skincare formulations, promoting the natural balance of the skin’s ecosystem. "Our expansion into Ukraine, Bulgaria, the Czech Republic, Slovakia, Kazakhstan, and Mexico allows us to fulfill our mission of reaching more users worldwide, partnered with a trusted company known for its commitment to quality and regional representation," he said.

Pioneering Probiotic Skincare

YUN's development of YUN Probiotherapy™, a patented microbiome-based platform, has revolutionized how skincare products can operate. By maintaining the natural dermal ecosystem through stable probiotics, YUN emphasizes the integration of nature with science in skincare. Their goal of improving the accessibility and effectiveness of probiotic skincare solutions resonates well with consumers increasingly seeking natural and scientifically validated products.

With this new phase of collaboration, Bausch Health and YUN are determined to elevate the availability of innovative probiotic solutions in skin care. Their partnership stands as a promising step towards enhancing the quality of life for consumers in global markets eager for effective skincare innovations that are safe for the skin microbiome.

For more information regarding these pioneering companies and their skincare solutions, check YUN's official website or follow them on LinkedIn.